Fennec Pharmaceuticals (FRX) News Today C$7.98 -0.32 (-3.86%) As of 01/17/2025 02:20 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Insider Selling: Fennec Pharmaceuticals Inc. (TSE:FRX) Director Sells 10,000 Shares of StockJanuary 9, 2025 | insidertrades.comFennec Pharmaceuticals Inc. (TSE:FRX) Director Sells C$87,552.00 in StockFennec Pharmaceuticals Inc. (TSE:FRX - Get Free Report) Director Rostislav Christov Raykov sold 10,000 shares of the firm's stock in a transaction dated Monday, January 6th. The shares were sold at an average price of C$8.76, for a total transaction of C$87,552.00.January 8, 2025 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Stock Price Passes Above Fifty Day Moving Average - Here's What HappenedFennec Pharmaceuticals (TSE:FRX) Shares Cross Above 50-Day Moving Average - Here's WhyJanuary 2, 2025 | marketbeat.comQ4 EPS Estimate for Fennec Pharmaceuticals Raised by AnalystFennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Wedbush increased their Q4 2024 earnings per share (EPS) estimates for Fennec Pharmaceuticals in a research report issued on Sunday, December 22nd. Wedbush analyst D. Nierengarten now anticipates that the biopharmaceutical company will post eaDecember 25, 2024 | marketbeat.comWedbush Raises Earnings Estimates for Fennec PharmaceuticalsFennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Equities researchers at Wedbush increased their Q3 2025 earnings per share (EPS) estimates for shares of Fennec Pharmaceuticals in a research note issued to investors on Sunday, December 22nd. Wedbush analyst D. Nierengarten now anticipates thDecember 24, 2024 | marketbeat.comRostislav Christov Raykov Acquires 25,000 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) StockDecember 24, 2024 | insidertrades.comFennec Pharmaceuticals Inc. (TSE:FRX) Director Acquires C$96,840.00 in StockFennec Pharmaceuticals Inc. (TSE:FRX - Get Free Report) Director Rostislav Christov Raykov purchased 25,000 shares of the stock in a transaction dated Friday, December 20th. The shares were purchased at an average price of C$3.87 per share, with a total value of C$96,840.00.December 23, 2024 | marketbeat.comFY2024 Earnings Forecast for TSE:FRX Issued By HC WainwrightFennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - HC Wainwright lowered their FY2024 EPS estimates for shares of Fennec Pharmaceuticals in a report issued on Tuesday, December 17th. HC Wainwright analyst R. Selvaraju now anticipates that the biopharmaceutical company will post earnings per shDecember 19, 2024 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Trading Down 0.3% - Time to Sell?Fennec Pharmaceuticals (TSE:FRX) Trading Down 0.3% - Here's WhyDecember 13, 2024 | marketbeat.comInsider Buying: Fennec Pharmaceuticals Inc. (TSE:FRX) Senior Officer Purchases 15,816 Shares of StockNovember 22, 2024 | insidertrades.comFennec Pharmaceuticals (TSE:FRX) Rating Increased to Strong-Buy at StephensStephens upgraded Fennec Pharmaceuticals to a "strong-buy" rating in a research note on Monday.November 20, 2024 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Shares Pass Below 50-Day Moving Average - Here's WhyFennec Pharmaceuticals (TSE:FRX) Share Price Crosses Below 50 Day Moving Average - Should You Sell?November 19, 2024 | marketbeat.comWedbush Cuts Earnings Estimates for Fennec PharmaceuticalsFennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Stock analysts at Wedbush decreased their FY2025 earnings per share (EPS) estimates for shares of Fennec Pharmaceuticals in a note issued to investors on Thursday, November 7th. Wedbush analyst D. Nierengarten now forecasts that the biopharmacNovember 11, 2024 | marketbeat.comFennec Pharmaceuticals (FENC) Gets a Buy from Craig-HallumNovember 7, 2024 | markets.businessinsider.comFennec Pharmaceuticals (FRX) Scheduled to Post Quarterly Earnings on ThursdayFennec Pharmaceuticals (TSE:FRX) will be releasing earnings before the market opens on Thursday, November 7, Zacks reports.November 1, 2024 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Stock Crosses Below 50-Day Moving Average - Time to Sell?Fennec Pharmaceuticals (TSE:FRX) Share Price Passes Below Fifty Day Moving Average - Time to Sell?October 29, 2024 | marketbeat.comFennec announces three executive appointmentsOctober 29, 2024 | markets.businessinsider.comCapital One Financial Estimates TSE:FRX Q3 EarningsFennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Capital One Financial increased their Q3 2024 earnings estimates for shares of Fennec Pharmaceuticals in a note issued to investors on Wednesday, October 16th. Capital One Financial analyst N. Quibria now forecasts that the biopharmaceutical cOctober 21, 2024 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Hits New 52-Week Low - Should You Sell?Fennec Pharmaceuticals (TSE:FRX) Sets New 52-Week Low - What's Next?October 8, 2024 | marketbeat.comFennec Pharmaceuticals Inc. (TSE:FRX) Director Rostislav Christov Raykov Sells 2,431 SharesOctober 5, 2024 | insidertrades.comRostislav Christov Raykov Sells 2,431 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) StockFennec Pharmaceuticals Inc. (TSE:FRX - Get Free Report) Director Rostislav Christov Raykov sold 2,431 shares of the stock in a transaction dated Wednesday, October 2nd. The shares were sold at an average price of C$6.67, for a total transaction of C$16,212.34.October 4, 2024 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Reaches New 12-Month Low at $7.00Fennec Pharmaceuticals (TSE:FRX) Sets New 52-Week Low at $7.00September 23, 2024 | marketbeat.comFennec Pharmaceuticals Inc. (TSE:FRX) Director Sells C$18,115.81 in StockSeptember 7, 2024 | insidertrades.comInsider Selling: Fennec Pharmaceuticals Inc. (TSE:FRX) Director Sells 2,431 Shares of StockFennec Pharmaceuticals Inc. (TSE:FRX - Get Free Report) Director Rostislav Christov Raykov sold 2,431 shares of the business's stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of C$7.45, for a total transaction of C$18,115.81.September 6, 2024 | marketbeat.comFennec Pharmaceuticals Inc.September 5, 2024 | wsj.comFennec Pharmaceuticals (TSE:FRX) Stock Price Crosses Below 50-Day Moving Average of $8.25Fennec Pharmaceuticals (TSE:FRX) Stock Passes Below Fifty Day Moving Average of $8.25September 3, 2024 | marketbeat.comCantor Fitzgerald Weighs in on Fennec Pharmaceuticals Inc.'s FY2024 Earnings (TSE:FRX)Fennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Equities research analysts at Cantor Fitzgerald cut their FY2024 EPS estimates for Fennec Pharmaceuticals in a note issued to investors on Thursday, August 22nd. Cantor Fitzgerald analyst C. Duncan now expects that the biopharmaceutical companAugust 26, 2024 | marketbeat.comFennec Pharmaceuticals Inc (FRX)August 16, 2024 | investing.comFennec Pharmaceuticals (TSE:FRX) Sets New 12-Month Low at $7.49Fennec Pharmaceuticals (TSE:FRX) Hits New 52-Week Low at $7.49August 14, 2024 | marketbeat.comFennec Pharmaceuticals Inc.: Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business UpdateAugust 14, 2024 | finanznachrichten.deFennec Pharmaceuticals Inc. (NASDAQ:FENC) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | msn.comResearch Analysts Offer Predictions for Fennec Pharmaceuticals Inc.'s Q2 2024 Earnings (TSE:FRX)Fennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Stock analysts at Capital One Financial cut their Q2 2024 earnings estimates for shares of Fennec Pharmaceuticals in a research note issued to investors on Monday, August 5th. Capital One Financial analyst N. Quibria now expects that the biophAugust 8, 2024 | marketbeat.comFennec Pharmaceuticals (FRX) to Release Earnings on TuesdayFennec Pharmaceuticals (TSE:FRX) will be releasing earnings before the market opens on Tuesday, August 13, Zacks reports.August 7, 2024 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Stock Price Crosses Below 50-Day Moving Average of $8.89Fennec Pharmaceuticals (TSE:FRX) Share Price Crosses Below Fifty Day Moving Average of $8.89August 6, 2024 | marketbeat.comFennec Pharma Names Hackman CEOAugust 5, 2024 | markets.businessinsider.comFennec Pharmaceuticals (TSE:FRX) Hits New 52-Week Low at $8.16Fennec Pharmaceuticals (TSE:FRX) Reaches New 12-Month Low at $8.16July 3, 2024 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Sets New 1-Year Low at $8.41Fennec Pharmaceuticals (TSE:FRX) Reaches New 52-Week Low at $8.41June 26, 2024 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Hits New 52-Week Low at $8.93Fennec Pharmaceuticals (TSE:FRX) Hits New 12-Month Low at $8.93June 20, 2024 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Stock Price Crosses Below 50 Day Moving Average of $11.14Fennec Pharmaceuticals (TSE:FRX) Stock Price Passes Below Fifty Day Moving Average of $11.14June 20, 2024 | marketbeat.comQ2 2024 EPS Estimates for Fennec Pharmaceuticals Inc. (TSE:FRX) Reduced by Capital One FinancialFennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Analysts at Capital One Financial dropped their Q2 2024 earnings per share (EPS) estimates for Fennec Pharmaceuticals in a report issued on Monday, June 10th. Capital One Financial analyst N. Quibria now anticipates that the biopharmaceuticalJune 12, 2024 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Hits New 1-Year Low at $9.00Fennec Pharmaceuticals (TSE:FRX) Hits New 1-Year Low at $9.00June 3, 2024 | marketbeat.comFY2024 EPS Estimates for Fennec Pharmaceuticals Inc. (TSE:FRX) Lowered by Cantor FitzgeraldFennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Stock analysts at Cantor Fitzgerald lowered their FY2024 earnings estimates for Fennec Pharmaceuticals in a research report issued on Wednesday, May 15th. Cantor Fitzgerald analyst C. Duncan now forecasts that the biopharmaceutical company wilMay 17, 2024 | marketbeat.comQ4 2025 Earnings Forecast for Fennec Pharmaceuticals Inc. Issued By HC Wainwright (TSE:FRX)Fennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - HC Wainwright lifted their Q4 2025 earnings estimates for Fennec Pharmaceuticals in a note issued to investors on Wednesday, May 15th. HC Wainwright analyst R. Selvaraju now forecasts that the biopharmaceutical company will post earnings per sMay 16, 2024 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Sets New 52-Week Low at $9.00Fennec Pharmaceuticals (TSE:FRX) Hits New 12-Month Low at $9.00May 14, 2024 | marketbeat.comFennec Pharmaceuticals Inc.: Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 14, 2024 | finanznachrichten.deFennec Pharmaceuticals (FRX) to Release Quarterly Earnings on TuesdayFennec Pharmaceuticals (TSE:FRX) will be releasing earnings before the market opens on Tuesday, May 14, Zacks reports.May 8, 2024 | marketbeat.comAdrian J. Haigh Sells 22,223 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) StockApril 24, 2024 | insidertrades.comFennec Pharmaceuticals Inc. (TSE:FRX) Senior Officer Adrian J. Haigh Acquires 22,222 SharesApril 17, 2024 | insidertrades.comAdrian J. Haigh Buys 22,222 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) StockFennec Pharmaceuticals Inc. (TSE:FRX - Get Free Report) Senior Officer Adrian J. Haigh purchased 22,222 shares of the firm's stock in a transaction that occurred on Monday, April 15th. The stock was bought at an average cost of C$2.31 per share, for a total transaction of C$51,332.82.April 16, 2024 | marketbeat.comInsider Sell: CEO Rosty Raykov Sells 88,583 Shares of Fennec Pharmaceuticals Inc (FENC)April 5, 2024 | finance.yahoo.com Get Fennec Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for FRX and its competitors with MarketBeat's FREE daily newsletter. Email Address FRX Media Mentions By Week FRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FRX News Sentiment▼0.000.57▲Average Medical News Sentiment FRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FRX Articles This Week▼01▲FRX Articles Average Week Get Fennec Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for FRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SLS News Today AIM News Today APM News Today ITH News Today GXE News Today CRDL News Today GPH News Today MDNA News Today EQ News Today CXF News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:FRX) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon's "Final Move" Could Send This Stock SoaringWhenever Elon Musk starts a new venture... Early investors get the opportunity to become millionaires... ...Behind the Markets | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fennec Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fennec Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FRX Stock Alerts